Total Payments
$329.17
2021 Payments
$23.93
Companies
11
Transactions
18
Medicare Patients
2,757
Medicare Billing
$218,036
Payment Breakdown by Category
Food & Beverage$305.24 (92.7%)
Education$23.93 (7.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $305.24 | 17 | 92.7% |
| Education | $23.93 | 1 | 7.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $48.27 | 3 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $47.16 | 3 | $0 (2017) |
| Astellas Pharma US Inc | $41.77 | 2 | $0 (2017) |
| Mallinckrodt LLC | $40.56 | 2 | $0 (2017) |
| AbbVie, Inc. | $29.29 | 2 | $0 (2017) |
| Dendreon Pharmaceuticals LLC | $25.03 | 1 | $0 (2017) |
| MEDIVATION INC. | $24.61 | 1 | $0 (2017) |
| Myovant Sciences Inc. | $23.93 | 1 | $0 (2021) |
| Endo Pharmaceuticals Inc. | $18.52 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $15.31 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $23.93 | 1 | Myovant Sciences Inc. ($23.93) |
| 2017 | $305.24 | 17 | Allergan Inc. ($48.27) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/27/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Education | In-kind items and services | $23.93 | General |
| Category: HORMONE THERAPY | ||||||
| 06/29/2017 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/28/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Oncology | ||||||
| 05/31/2017 | AbbVie, Inc. | Lupron (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Endocrinology | ||||||
| 05/24/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Oncology | ||||||
| 05/17/2017 | Mallinckrodt LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: ACUTE CARE | ||||||
| 05/02/2017 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), TESTOPEL, AVEED | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: ORTHOPEDICUROLOGY | ||||||
| 04/19/2017 | MEDIVATION INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: ONCOLOGY | ||||||
| 04/12/2017 | Allergan Inc. | BOTOX OAB (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: OVER ACTIVE BLADDER | ||||||
| 04/06/2017 | Mission Pharmacal Company | Uribel (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Analgesic, antispasmodic & antiseptic (urinary) | ||||||
| 03/22/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Oncology | ||||||
| 03/22/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Oncology | ||||||
| 03/17/2017 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.11 | General |
| 03/15/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Oncology | ||||||
| 02/22/2017 | Mallinckrodt LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: ACUTE CARE | ||||||
| 02/08/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Oncology | ||||||
| 02/01/2017 | AbbVie, Inc. | Lupron (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Endocrinology | ||||||
| 01/24/2017 | Allergan Inc. | ESTRACE CREAM (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 8 | 415 | 477 | $101,489 | $29,344 |
| 2021 | 9 | 984 | 1,193 | $261,821 | $79,855 |
| 2020 | 16 | 1,358 | 1,944 | $368,284 | $108,837 |
Total Patients
2,757
Total Services
3,614
Medicare Billing
$218,036
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 222 | 263 | $56,620 | $16,863 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 84 | 102 | $14,268 | $4,441 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 31 | 31 | $10,893 | $2,624 | 24.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 20 | 22 | $6,665 | $2,433 | 36.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 23 | 24 | $6,131 | $1,279 | 20.9% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 11 | 11 | $4,532 | $1,054 | 23.3% |
| 99451 | Telephone or internet assessment with written report by consulting physician, 5 minutes or more | Facility | 2022 | 12 | 12 | $1,203 | $343.86 | 28.6% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2022 | 12 | 12 | $1,177 | $305.84 | 26.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 218 | 264 | $56,522 | $22,153 | 39.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 198 | 255 | $74,919 | $20,654 | 27.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 141 | 183 | $37,076 | $10,693 | 28.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 86 | 110 | $15,312 | $6,258 | 40.9% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 32 | 36 | $23,504 | $5,626 | 23.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 47 | 47 | $16,516 | $5,068 | 30.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 45 | 45 | $20,003 | $4,690 | 23.4% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 35 | 38 | $9,652 | $2,635 | 27.3% |
| 51700 | Bladder irrigation and/or instillation | Office | 2021 | 11 | 15 | $3,500 | $846.82 | 24.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 61 | 66 | $2,086 | $485.39 | 23.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 87 | 104 | $904.80 | $307.00 | 33.9% |
| 99451 | Telephone or internet assessment and management service provided by consultative physician with written report, 5 minutes or more of medical consultative discussion and review | Office | 2021 | 11 | 11 | $1,098 | $241.81 | 22.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 12 | 19 | $729.60 | $197.24 | 27.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 362 | 453 | $122,033 | $33,379 | 27.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2020 | 19 | 136 | $50,014 | $22,664 | 45.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 220 | 335 | $61,282 | $16,601 | 27.1% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 61 | 77 | $47,658 | $11,412 | 23.9% |
About Dr. James Downey, MD
Dr. James Downey, MD is a Urology healthcare provider based in Mountlake Terrace, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1982688552.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Downey, MD has received a total of $329.17 in payments from pharmaceutical and medical device companies, with $23.93 received in 2021. These payments were reported across 18 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($305.24).
As a Medicare-enrolled provider, Downey has provided services to 2,757 Medicare beneficiaries, totaling 3,614 services with total Medicare billing of $218,036. Data is available for 3 years (2020–2022), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Mountlake Terrace, WA
- Active Since 12/06/2005
- Last Updated 04/03/2008
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1982688552
Products in Payments
- Xofigo (Drug) $47.16
- Xtandi (Drug) $41.77
- OFIRMEV (Drug) $40.56
- Lupron (Drug) $29.29
- PROVENGE (Drug) $25.03
- XTANDI (Drug) $24.61
- ORGOVYX (Drug) $23.93
- BOTOX (Biological) $19.11
- XIAFLEX (Biological) $18.52
- BOTOX OAB (Drug) $16.85
- ZYTIGA (Drug) $15.31
- Uribel (Drug) $14.72
- ESTRACE CREAM (Drug) $12.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.